H. C. van Prooijen

580 total citations
25 papers, 483 citations indexed

About

H. C. van Prooijen is a scholar working on Hematology, Biochemistry and Management of Technology and Innovation. According to data from OpenAlex, H. C. van Prooijen has authored 25 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 13 papers in Biochemistry and 5 papers in Management of Technology and Innovation. Recurrent topics in H. C. van Prooijen's work include Blood transfusion and management (12 papers), Platelet Disorders and Treatments (10 papers) and Hematopoietic Stem Cell Transplantation (6 papers). H. C. van Prooijen is often cited by papers focused on Blood transfusion and management (12 papers), Platelet Disorders and Treatments (10 papers) and Hematopoietic Stem Cell Transplantation (6 papers). H. C. van Prooijen collaborates with scholars based in Netherlands, Germany and United States. H. C. van Prooijen's co-authors include M. Bins, Janny De Wildt‐Eggen, K. Punt, J.W.N. Akkerman, A. W. Dekker, Marinus van Marwijk Kooy, J. Visser, Leo F. Verdonck, G C de Gast and H. van Weelden and has published in prestigious journals such as British Journal of Haematology, Thrombosis and Haemostasis and Transfusion.

In The Last Decade

H. C. van Prooijen

25 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. C. van Prooijen Netherlands 13 302 255 126 50 47 25 483
L Bardossy Canada 10 279 0.9× 299 1.2× 73 0.6× 88 1.8× 31 0.7× 16 572
R. Tardivel France 11 342 1.1× 399 1.6× 197 1.6× 38 0.8× 38 0.8× 17 600
M. Dean Elfath United States 10 296 1.0× 347 1.4× 201 1.6× 34 0.7× 15 0.3× 16 476
Pranee Krailadsiri United Kingdom 17 413 1.4× 401 1.6× 256 2.0× 40 0.8× 68 1.4× 47 692
Annie Strupp United States 9 226 0.7× 394 1.5× 255 2.0× 31 0.6× 18 0.4× 9 612
Luba Klama Canada 7 402 1.3× 474 1.9× 176 1.4× 47 0.9× 18 0.4× 7 665
M. J. Dijkstra‐Tiekstra Netherlands 11 173 0.6× 218 0.9× 108 0.9× 33 0.7× 24 0.5× 23 361
P. R. Sohmer United States 10 135 0.4× 185 0.7× 57 0.5× 29 0.6× 18 0.4× 15 397
JP Dutcher United States 8 311 1.0× 180 0.7× 24 0.2× 16 0.3× 17 0.4× 14 424
Edward E. Morse United States 10 160 0.5× 50 0.2× 29 0.2× 42 0.8× 27 0.6× 17 384

Countries citing papers authored by H. C. van Prooijen

Since Specialization
Citations

This map shows the geographic impact of H. C. van Prooijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. van Prooijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. van Prooijen more than expected).

Fields of papers citing papers by H. C. van Prooijen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. C. van Prooijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. van Prooijen. The network helps show where H. C. van Prooijen may publish in the future.

Co-authorship network of co-authors of H. C. van Prooijen

This figure shows the co-authorship network connecting the top 25 collaborators of H. C. van Prooijen. A scholar is included among the top collaborators of H. C. van Prooijen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. C. van Prooijen. H. C. van Prooijen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wildt‐Eggen, Janny De, et al.. (1997). Improvement of platelet storage conditions by using new polyolefin containers. Transfusion. 37(5). 476–481. 40 indexed citations
3.
Wildt‐Eggen, Janny De, M. Bins, & H. C. van Prooijen. (1996). Evaluation of Storage Conditions of Platelet Concentrates Prepared from Pooled Buffy Coats. Vox Sanguinis. 70(1). 11–15. 16 indexed citations
4.
Wildt‐Eggen, Janny De, M. Bins, & H. C. van Prooijen. (1996). Evaluation of Storage Conditions ofPlatelet Concentrates Prepared fromPooled Buffy Coats. Vox Sanguinis. 70(1). 11–15. 1 indexed citations
5.
Prooijen, H. C. van, et al.. (1995). Prevention of donor‐specific T‐cell unresponsiveness after buffy‐coat‐depleted blood transfusion. British Journal of Haematology. 91(1). 219–223. 12 indexed citations
7.
Claas, Frans H.J., et al.. (1994). Prevention of MHC‐alloimmunization by UV‐B irradiation in a murine model: effects of UV dose and number of transfused cells. British Journal of Haematology. 87(3). 598–604. 12 indexed citations
8.
Kooy, Marinus van Marwijk, et al.. (1993). UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species. British Journal of Haematology. 83(2). 253–258. 34 indexed citations
9.
Akkerman, J.W.N., et al.. (1993). Ultraviolet‐B irradiation of platelets induces a dose‐dependent increase in the expression of platelet activation markers with storage. British Journal of Haematology. 83(4). 627–632. 15 indexed citations
10.
Prooijen, H. C. van, et al.. (1992). Ultraviolet irradiation modulates MHC‐alloreactive cytotoxic T‐cell precursors involved in the onset of graft‐versus‐host disease. British Journal of Haematology. 81(1). 73–76. 12 indexed citations
11.
Kooy, Marinus van Marwijk, et al.. (1990). Irradiation of platelets with UV‐B light exposes fibrinogen binding sites via an intracellular mechanism. British Journal of Haematology. 76(4). 531–536. 9 indexed citations
12.
Prooijen, H. C. van, et al.. (1990). Evaluation of a new UVB source for irradiation of platelet concentrates. British Journal of Haematology. 75(4). 573–577. 18 indexed citations
13.
Prooijen, H. C. van, et al.. (1990). Filtration. A method to prepare white cell‐poor platelet concentrates with optimal preservation of platelet viability. Transfusion. 30(1). 34–38. 24 indexed citations
14.
Prooijen, H. C. van, et al.. (1989). Differences in the susceptibility of platelets to freezing damage in relation to size. Transfusion. 29(6). 539–543. 4 indexed citations
15.
Prooijen, H. C. van, et al.. (1987). Cryopreservation disturbs stimulus‐response coupling in a platelet subpopulation. British Journal of Haematology. 67(3). 325–333. 9 indexed citations
16.
Prooijen, H. C. van, et al.. (1987). Cryopreservation disturbs stimulus-response coupling in a platelet subpopulation. British Journal of Haematology. 67(3). 325–333. 5 indexed citations
17.
Prooijen, H. C. van, et al.. (1987). INCREASED SENSITIVITY OF A PLATELET-SUBPOPULATION TO CRYOPRESERVATION. Thrombosis and Haemostasis. 1 indexed citations
18.
Prooijen, H. C. van, K. Punt, & Petra Muus. (1985). CEREBROSPINAL FLUID CONCENTRATIONS OF CYTOSINE ARABINOSIDE DURING INTRAVENOUS THERAPY WITH INTERMEDIATE DOSE: A PRELIMINARY REPORT. British Journal of Haematology. 59(1). 188–190. 5 indexed citations
19.
Prooijen, H. C. van, A. W. Dekker, & K. Punt. (1984). The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapse. British Journal of Haematology. 57(2). 291–299. 1 indexed citations
20.
Prooijen, H. C. van, G. Vierwinden, J. van Egmond, J.M.C. Wessels, & C. Haanen. (1976). A sensitive bio-assay for pharmacokinetic studies of cytosine arabinoside in man. European Journal of Cancer (1965). 12(11). 899–905. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026